Fidelity Advisor Biotechnology Fund Class A Current Assets

Fidelity Advisor Biotechnology Fund Class A posts a current assets of $130M as of February 2024. That compares with $150M in the prior-year period — down 13.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Fidelity Advisor Biotechnology Fund Class A's current assets was $150M. The latest reading is $130M — a 13.3% year-over-year decrease (period ending February 2024). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Fidelity Advisor Biotechnology Fund Class A's financial statement story. At $130M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FBTAX's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fidelity Advisor Biotechnology Fund Class A's other metric pages and overview cover the third.